Clincosm LogoSign in Get a demo

Soft Tissue Sarcoma

Showing 51 - 75 of 232
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Guangzhou, Beijing (NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy))

Recruiting
  • Soft Tissue Sarcoma
  • NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
  • Guangzhou, Guangdong, China
  • +1 more
Sep 18, 2022

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 16, 2022

Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)

Recruiting
  • Soft Tissue Sarcoma
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 14, 2022

Malignant Solid Tumors, Primary Brain Tumor, Melanoma Trial in Saint Petersburg

Recruiting
  • Malignant Solid Tumors
  • +6 more
    • Saint Petersburg, Russian Federation
      N.N. Petrov NMRC of Oncology, Oncoimmunology dep.
    Sep 13, 2022

    Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

    Recruiting
    • Soft Tissue Sarcoma
    • +4 more
    • Scottsdale, Arizona
    • +9 more
    Sep 13, 2022

    Soft Tissue Sarcoma Trial in Guangzhou (Sintilimab plus chemo)

    Recruiting
    • Soft Tissue Sarcoma
    • Sintilimab plus chemotherapy
    • Guangzhou, Guangdong, China
      Xing Zhang
    Sep 4, 2022

    Soft Tissue Sarcoma Trial in Guangzhou (Toripalimab Combined With CAV / IE Regimen chemo)

    Recruiting
    • Soft Tissue Sarcoma
    • Toripalimab Combined With CAV / IE Regimen chemotherapy
    • Guangzhou, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2022

    Lymph Node Basins and Surgical Practice Patterns Among Sarcoma

    Recruiting
    • Soft Tissue Sarcoma
    • Lymph Node Cancer
    • Survey Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Soft Tissue Sarcoma Trial in Worldwide (Olaratumab)

    Available
    • Soft Tissue Sarcoma
    • Glendale, Arizona
    • +92 more
    Aug 17, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • Toronto, Ontario, Canada
      University Health Network - Princess Margaret Cancer Centre
    Aug 16, 2022

    Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)

    Recruiting
    • Soft Tissue Sarcoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Aug 10, 2022

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

    Recruiting
    • Resectable Soft Tissue Sarcoma
    • Soft Tissue Sarcoma
    • Goodyear, Arizona
    • +52 more
    Jul 21, 2022

    Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Pembrolizumab)

    Active, not recruiting
    • Soft Tissue Sarcoma
    • Boston, Massachusetts
    • +5 more
    Jul 19, 2022

    Solid Tumor, Adult, Metastatic Cancer, Soft Tissue Sarcoma Trial in Belgium, France (BT-001, Pembrolizumab [Keytruda])

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • BT-001
    • Pembrolizumab [Keytruda]
    • Brussels, Belgium
    • +4 more
    Jul 13, 2022

    Soft Tissue Sarcoma Trial (Ga-68-PSMA-11 PET/CT, Lu-177-ITG-PSMA-1)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • (no location specified)
    Jul 7, 2022

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Soft Tissue Sarcoma Trial in China (LVGN6051 and Anlotinib)

    Recruiting
    • Soft Tissue Sarcoma
    • LVGN6051 and Anlotinib
    • Zhenzhou, Henan, China
    • +4 more
    May 31, 2022

    Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

    Completed
    Has Results
    • Small Cell Lung Cancer
    • +7 more
    • PDR001
    • LAG525
    • San Francisco, California
    • +19 more
    May 4, 2022

    Soft Tissue Sarcoma Trial in United States (Intensity-modulated radiation therapy (IMRT))

    Recruiting
    • Soft Tissue Sarcoma
    • Intensity-modulated radiation therapy (IMRT)
    • Basking Ridge, New Jersey
    • +6 more
    May 16, 2022

    Soft Tissue Sarcoma Trial in Madison (Conventional Fractionated, Hypofractionated)

    Recruiting
    • Soft Tissue Sarcoma
    • Conventional Fractionated
    • Hypofractionated
    • Madison, Wisconsin
      University of Wisconsin Hospital and Clinics
    May 6, 2022

    Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)

    Active, not recruiting
    Has Results
    • Soft Tissue Sarcoma
    • Talimogene Laherparepvec
    • Radiotherapy
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    May 4, 2022

    Soft Tissue Sarcoma Trial in France (Standard of care + chemo, Standard of care)

    Recruiting
    • Soft Tissue Sarcoma
    • Standard of care + chemotherapy
    • Standard of care
    • Besançon, France
    • +21 more
    May 3, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022